Ipca Laboratories has announced that its Board of Directors will meet on Friday, February 13, 2026, to review and approve the Standalone and Consolidated Unaudited Financial Results for the third quarter and nine months ending December 31, 2025. The trading window remains closed until 48 hours after the results are declared.
Board Meeting Announcement
The Board of Directors of Ipca Laboratories is scheduled to convene on February 13, 2026, to discuss and approve the company’s financial performance.
Financial Results on Agenda
During the meeting, the board will primarily focus on reviewing and taking on record the Standalone and Consolidated Unaudited Financial Results for Q3 and the nine months ending December 31, 2025. This provides investors with an insight into the company’s performance during this period.
Trading Window Closure
As per company policy, the trading window for company insiders remains closed and will re-open 48 hours after the declaration of the unaudited financial results. The closure commenced on January 1, 2026, and extends until February 15, 2026.
Source: BSE
